HomeCompareWENA vs NNN

WENA vs NNN: Dividend Comparison 2026

WENA yields 275.48% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WENA wins by $860.05M in total portfolio value
10 years
WENA
WENA
● Live price
275.48%
Share price
$0.73
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$860.08M
Annual income
$501,772,088.45
Full WENA calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — WENA vs NNN

📍 WENA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWENANNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WENA + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WENA pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WENA
Annual income on $10K today (after 15% tax)
$23,415.98/yr
After 10yr DRIP, annual income (after tax)
$426,506,275.18/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, WENA beats the other by $426,504,033.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WENA + NNN for your $10,000?

WENA: 50%NNN: 50%
100% NNN50/50100% WENA
Portfolio after 10yr
$430.05M
Annual income
$250,887,362.94/yr
Blended yield
58.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

WENA
No analyst data
Altman Z
-1.8
Piotroski
1/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WENA buys
0
NNN buys
0
No recent congressional trades found for WENA or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWENANNN
Forward yield275.48%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$860.08M$25.6K
Annual income after 10y$501,772,088.45$2,637.42
Total dividends collected$823.11M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: WENA vs NNN ($10,000, DRIP)

YearWENA PortfolioWENA Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$38,248$27,548.21$10,737$617.02+$27.5KWENA
2$139,399$98,473.80$11,577$710.93+$127.8KWENA
3$484,576$335,418.24$12,538$822.59+$472.0KWENA
4$1,608,187$1,089,691.52$13,645$956.06+$1.59MWENA
5$5,100,591$3,379,830.49$14,925$1,116.51+$5.09MWENA
6$15,475,954$10,018,322.01$16,415$1,310.57+$15.46MWENA
7$44,967,761$28,408,489.97$18,158$1,546.77+$44.95MWENA
8$125,260,578$77,145,073.44$20,213$1,836.20+$125.24MWENA
9$334,862,969$200,834,150.89$22,649$2,193.37+$334.84MWENA
10$860,075,466$501,772,088.45$25,558$2,637.42+$860.05MWENA

WENA vs NNN: Complete Analysis 2026

WENAStock

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

Full WENA Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this WENA vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WENA vs SCHDWENA vs JEPIWENA vs OWENA vs KOWENA vs MAINWENA vs ADCWENA vs EPRTWENA vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.